Autonomix Medical Launches Highly Dilutive $10.5M ATM Offering, Potentially Doubling Share Count
AMIX sits 79% above its 52-week low of $2.44.
Summary
Autonomix Medical launched a new $10.5 million ATM offering, which could more than double its outstanding shares, as it seeks to fund operations amidst a 'going concern' warning and Nasdaq delisting risk.
Key Events · Financing and Capital Events · AMIX
-
New $10.5M At-The-Market (ATM) Offering
Autonomix Medical has launched a new at-the-market (ATM) equity offering to sell up to $10.525 million of common stock through Ladenburg Thalmann & Co. Inc. This follows a prior $1.35 million ATM program initiated on July 31, 2026.
-
Significant Potential Dilution
If fully utilized at the reference price of $4.58 per share (the closing price on September 8, 2026), this offering could issue approximately 2,298,035 new shares. This represents about 117% of the 1,959,938 shares currently outstanding as of September 8, 2026, indicating substantial dilution for existing shareholders.
-
Critical Capital Raise Amidst Financial Distress
This capital raise is crucial for the company, which has a 'going concern' warning and faces a Nasdaq delisting risk due to its market value. The company's last 10-Q (August 13, 2026) indicated a cash runway only into Q1 2027 and a need for $25-30 million to reach commercialization.
-
Proceeds for Working Capital
The net proceeds from this offering are intended for working capital and general corporate purposes, which is standard for companies in a development stage requiring ongoing funding.
Analysis · AMIX · Industrial Applications And Services
Autonomix Medical has initiated a substantial at-the-market (ATM) offering to raise up to $10.525 million. This capital raise is critical for the company, which is a development-stage medical device firm operating under a "going concern" warning and facing a Nasdaq delisting risk due to its market value. The company previously disclosed a need for $25-30 million to reach commercialization. While necessary for short-term survival, the potential dilution for existing shareholders is severe, as the offering could issue shares equivalent to more than the current outstanding share count.
How filings like this one have moved
In the 30 days to Sep 11, 2026, 41.8% of the 507 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.39%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AMIX was trading at $4.37 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $8M. The 52-week trading range was $2.44 to $32.55. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.